These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 10821260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K, Nielsen HJ.
    Ugeskr Laeger; 2000 Sep 11; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS.
    J Clin Oncol; 2000 Nov 01; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract] [Full Text] [Related]

  • 5. [The function and application of vascular endothelial growth factor].
    Zhang M, Zhou AR.
    Sheng Li Ke Xue Jin Zhan; 1996 Jul 01; 27(3):255-7. PubMed ID: 9772368
    [No Abstract] [Full Text] [Related]

  • 6. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S, Lyden D, Benezra R, Hattori K, Heissig B.
    Nat Rev Cancer; 2002 Nov 01; 2(11):826-35. PubMed ID: 12415253
    [No Abstract] [Full Text] [Related]

  • 7. A siren song from tumor cells.
    Cavenee WK.
    J Clin Invest; 1993 Jan 01; 91(1):3. PubMed ID: 7678605
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vascular permeability factor/vascular endothelial growth factor and vascular stroma formation in neoplasia. Insights from in situ hybridization studies.
    Brown LF, Guidi AJ, Tognazzi K, Dvorak HF.
    J Histochem Cytochem; 1998 May 01; 46(5):569-75. PubMed ID: 9562567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G, Heidenreich R, Gaumann A, Groot M, Licht A, Nicolaus A, Schmitz J, Reichmann E, Plate KH, Vajkoczy P.
    Ann Hematol; 2002 May 01; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanism of thrombin-induced angiogenesis.
    Maragoudakis ME, Tsopanoglou NE, Andriopoulou P.
    Biochem Soc Trans; 2002 Apr 01; 30(2):173-7. PubMed ID: 12023846
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors.
    Neufeld G, Kessler O, Vadasz Z, Gluzman-Poltorak Z.
    Surg Oncol Clin N Am; 2001 Apr 01; 10(2):339-56, ix. PubMed ID: 11382591
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.